STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...
Remains on track to name a development candidate for a novel first-in-class neurology program targeting demyelinating diseases in 2026Progresses discovery work on a best-in-class cell therapeutic ...
AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research ...
The Warburg effect describes how cancer cells switch from oxidative phosphorylation to glycolysis even in oxygen-rich ...
ACEMAGIC unveiled its latest Mini PC lineup at CES 2026, highlighting significant advancements in local AI computing, content creation and gaming ...
Shoplazza, a global commerce platform serving direct-to-consumer (DTC) brands, on January 7 announced the launch of Fulfillment by Shoplazza (FBS), a comprehensive fulfillment infrastructure designed ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...
Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...
Scientists are literally turning back the clocks in our cells, with the first drugs about to go to human trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results